이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

BCG-나이브 고위험 비근육 침습성 방광암 환자에서 Cetrelimab 또는 TAR-200 단독 대 방광내 Bacillus Calmette-Guérin(BCG)과의 TAR-200 병용 연구 (SunRISe-3)

2026년 9월 24일 업데이트: Janssen Research & Development, LLC

TAR-200과 Cetrelimab 병용 또는 TAR-200 단독 대 방광 내 Bacillus Calmette-Guérin(BCG)의 효능 및 안전성을 BCG에 노출되지 않은 고위험 환자에서 평가하는 3상, 오픈 라벨, 다기관, 무작위 연구 비근육 침습성 방광암

The purpose of this study is to compare event-free survival (EFS) in participants with Bacillus Calmette-Guerin (BCG)-naive high-risk non-muscle invasive bladder cancer (HR-NMIBC), including high-grade papillary Ta, any T1, or carcinoma in situ (CIS), between TAR-200 plus cetrelimab (Group A) and TAR-200 alone (Group C) versus intravesical BCG (Group B).

연구 개요

상태

모집하지 않고 적극적으로

정황

상세 설명

Bladder cancer is the tenth most common malignancy worldwide. About 75 percent (%) of bladder cancers are non-muscle invasive at diagnosis with approximately 25% of NMIBC patients have HR, NMIBC. The TAR-200/gemcitabine (JNJ-17000139) product is an intravesical drug delivery system regulated as an investigational drug. The drug constituent consists of gemcitabine and osmotic minitablets. Cetrelimab (JNJ-63723283) is a fully human immunoglobulin G4 (IgG4) kappa monoclonal antibody (mAb) that binds programmed-cell death protein (PD)-1. The mainstay of treatment for HR-NMIBC is transurethral resection of bladder tumor, followed by intravesical treatment with BCG. In this study metronomic dosing of intravesical gemcitabine, delivered via TAR-200, alone or in combination with cetrelimab will be evaluated and compared against intravesical BCG. The study consists of a Screening phase, Treatment phase, and Follow-up phase. The total duration of the study will be up to 5 years and 2 months. Efficacy, Safety, pharmacokinetics (PK), and biomarkers will be assessed at specific time points during the study.

연구 유형

중재적

등록 (실제)

1135

단계

  • 3단계

확장된 액세스

승인됨 대중에게 판매합니다. 확장 액세스 기록을 참조하세요.

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Hoofddorp, 네덜란드, 2134 TM
        • Spaarne Gasthuis
      • Nijmegen, 네덜란드, 6524 KD
        • Canisius-Wilhelmina Ziekenhuis
      • Nijmegen, 네덜란드, 6525 GA
        • Radboud Umcn
      • Kaohsiung City, 대만, 833
        • Chang Kung Memorial Hospital
      • Kaohsiung City, 대만, 807
        • Kaohsiung Medical University Chung Ho Memorial Hospital
      • Taichung, 대만, 404
        • China Medical University Hospital
      • Taichung, 대만, 40705
        • Taichung Veterans General Hospital
      • Taipei, 대만, 11217
        • Taipei Veterans General Hospital
      • Taoyuan, 대만, 33382
        • Linkou Chang Gung Memorial Hospital
      • Busan, 대한민국, 49241
        • Pusan National University Hospital
      • Cheongju-si, 대한민국, 28644
        • Chungbuk National University Hospital
      • Daegu, 대한민국, 41404
        • Kyungpook National University Chilgok Hospital
      • Daegu, 대한민국, 42601
        • Keimyung University Dongsan Hospital
      • Gyeonggi-do, 대한민국, 10408
        • National Cancer Center
      • Jeollanam-do, 대한민국, 58128
        • Chonnam National University Hwasun Hospital
      • Seoul, 대한민국, 03080
        • Seoul National University Hospital
      • Seoul, 대한민국, 03722
        • Severance Hospital Yonsei University Health System
      • Seoul, 대한민국, 06351
        • Samsung Medical Center
      • Seoul, 대한민국, 03181
        • Kangbuk Samsung Hospital
      • Seoul, 대한민국, 06591
        • The Catholic University of Korea Seoul St Marys Hospital
      • Seoul, 대한민국, 02841
        • Korea University Anam Hospital
      • Cologne, 독일, 50968
        • Urologische Partnerschaft Koln UPK
      • Duisburg, 독일, 47169
        • Urologicum Duisburg
      • Erlangen, 독일, 91054
        • Universitatsklinikum Erlangen
      • Essen, 독일, 45147
        • Universitatsklinikum Essen
      • Frankfurt am Main, 독일, 60590
        • Universitaetsklinikum Frankfurt
      • Freiburg im Breisgau, 독일, 79106
        • Universitaetsklinikum Freiburg
      • Markkleeberg, 독일, 04416
        • Matthias Schulze - Germany
      • Mettmann, 독일, 40822
        • Urologie Neandertal Praxis Mettmann
      • München, 독일, 81675
        • Klinikum rechts der Isar an der Technischen Universitat Munchen
      • Münster, 독일, 48149
        • Universitatsklinikum Munster
      • Nuremberg, 독일, 90491
        • Medizinisches Versorgungszentrum - Urologie
      • Nuremberg, 독일, 90419
        • Klinikum Nurnberg Nord
      • Nürtingen, 독일, 72622
        • Studienpraxis Urologie Nurtingen
      • Regensburg, 독일, 93053
        • Caritas-Krankenhaus St. Josef
      • Tübingen, 독일, 72076
        • Universitat Tubingen
      • Mexico City, 멕시코, 14308
        • Consultorio Medico dentro del Hospital Angeles Acoxpa
      • Monterrey, 멕시코, 64460
        • Hospital Universitario Dr Jose Eleuterio Gonzalez
      • Monterrey, 멕시코, 64710
        • Avix Investigacion Clinica S C
      • Mérida, 멕시코, 97000
        • Eme Red Hospitalaria
      • San Luis Potosí City, 멕시코, 78260
        • Oncologico Potosino
    • Arizona
      • Scottsdale, Arizona, 미국, 85259
        • Mayo Clinic
    • Arkansas
      • Little Rock, Arkansas, 미국, 72211
        • Arkansas Urology
    • California
      • Long Beach, California, 미국, 90822
        • VA Long Beach Health Care System
      • Los Alamitos, California, 미국, 90720
        • Genesis Research, LLC - West Coast Urology
      • Los Angeles, California, 미국, 90048
        • Cedars Sinai Medical Center
      • Sacramento, California, 미국, 95630
        • UC Davis Comprehensive Cancer Center
      • San Diego, California, 미국, 92123
        • Genesis Research
      • Santa Monica, California, 미국, 90404
        • Providence Saint Johns Cancer Institute
      • Santa Rosa, California, 미국, 95403
        • Providence Medical Foundation
    • Colorado
      • Lakewood, Colorado, 미국, 80228
        • Colorado Clinical Research
    • Florida
      • Hialeah, Florida, 미국, 33016
        • Urological Research Network
      • Orlando, Florida, 미국, 32806
        • Orlando Health Cancer Institute
      • Sarasota, Florida, 미국, 34239
        • Sarasota Memorial Hospital
    • Georgia
      • Atlanta, Georgia, 미국, 30303
        • Grady Memorial Hospital
      • Atlanta, Georgia, 미국, 30322
        • The Emory Clinic Department of Urology
    • Illinois
      • Chicago, Illinois, 미국, 60611
        • Northwestern University
      • Lisle, Illinois, 미국, 60532
        • Duly Health and Care
      • Quincy, Illinois, 미국, 62301
        • Blessing Hospital
    • Indiana
      • Carmel, Indiana, 미국, 46032
        • Urology of Indiana
      • Jeffersonville, Indiana, 미국, 47130
        • First Urology
    • Kansas
      • Merriam, Kansas, 미국, 66204
        • AMR Kansas City Oncology
      • Wichita, Kansas, 미국, 67226
        • Wichita Urology Group
    • Maryland
      • Hanover, Maryland, 미국, 21076
        • Chesapeake Urology Research Associates
    • Massachusetts
      • Burlington, Massachusetts, 미국, 01805
        • Lahey Hospital & Medical Center
    • Michigan
      • Ann Arbor, Michigan, 미국, 48109
        • University of Michigan
    • Minnesota
      • Minneapolis, Minnesota, 미국, 55455
        • University Of Minnesota
      • Rochester, Minnesota, 미국, 55905
        • Mayo Clinic Rochester
    • Nebraska
      • Omaha, Nebraska, 미국, 68114
        • The Urology Center, PC
    • New Jersey
      • Camden, New Jersey, 미국, 08103
        • Cooper Health System MD Anderson Cancer Center at Cooper
    • New York
      • New York, New York, 미국, 10029
        • Icahn School of Medicine at Mt. Sinai
      • New York, New York, 미국, 10010
        • VA NY Harbor Healthcare System
      • Syracuse, New York, 미국, 13210
        • SUNY Upstate Med Univ
      • Syracuse, New York, 미국, 13210
        • Associated Medical Professionals of Ny
    • North Carolina
      • Greenville, North Carolina, 미국, 27834
        • Vidant Urology - Greenville
    • Ohio
      • Cleveland, Ohio, 미국, 44195
        • Cleveland Clinic
      • Gahanna, Ohio, 미국, 43230
        • Central Ohio Urology Group
    • Pennsylvania
      • Bala-Cynwyd, Pennsylvania, 미국, 19004
        • Centers for Advanced Urology LLC d b a MidLantic Urology
      • Philadelphia, Pennsylvania, 미국, 19107
        • Thomas Jefferson University Hospital
      • Pittsburgh, Pennsylvania, 미국, 15232
        • UPMC Shadyside Hospital
    • South Carolina
      • Myrtle Beach, South Carolina, 미국, 29572
        • Carolina Urologic Research Center
    • Tennessee
      • Nashville, Tennessee, 미국, 37232
        • Vanderbilt University Medical Center
      • Nashville, Tennessee, 미국, 37209
        • Urology Associates
    • Texas
      • Austin, Texas, 미국, 78745
        • Urology Austin
      • Dallas, Texas, 미국, 75231
        • Urology Clinics of North Texas
      • Houston, Texas, 미국, 77030
        • Houston Methodist Hospital
      • Houston, Texas, 미국, 77027
        • Houston Metro Urology
      • San Antonio, Texas, 미국, 78229
        • Urology San Antonio Research
    • Utah
      • Salt Lake City, Utah, 미국, 84112
        • Huntsman Cancer Institute
      • Salt Lake City, Utah, 미국, 84148
        • George E. Wahlen VAMC
    • Virginia
      • Virginia Beach, Virginia, 미국, 23462
        • Urology Of Virginia, Pllc
    • Washington
      • Spokane, Washington, 미국, 99202
        • Spokane Urology
      • Antwerp, 벨기에, 2020
        • ZNA Middelheim
      • Bruges, 벨기에, 8000
        • AZ Sint-Jan
      • Bruges, 벨기에, 8310
        • AZ Sint-Lucas
      • Ghent, 벨기에, 9000
        • AZ Maria Middelares
      • Ghent, 벨기에, 9000
        • UZ Gent
      • Libramont-Chevigny, 벨기에, 6800
        • Centre Hospitalier de l'Ardenne
      • Roeselare, 벨기에, 8800
        • AZ Delta
      • Sint-Niklaas, 벨기에, 9100
        • Vitaz
      • Wilrijk, 벨기에, 2610
        • GZA Ziekenhuizen- Campus St Augustinus
      • Barretos, 브라질, 14784-400
        • Fundacao Pio XII
      • Bauru, 브라질, 17033-495
        • NAIC Nair Antunes Instituto do Cancer
      • Campinas, 브라질, 13083-888
        • Hospital das Clinicas da Universidade Estadual de Campinas UNICAMP
      • Curitiba, 브라질, 81520-060
        • Hospital Erasto Gaertner- Liga Paranaense de Combate ao Cancer
      • Natal, 브라질, 59075-740
        • Liga Norte Riograndense Contra O Cancer
      • Porto Alegre, 브라질, 90050-170
        • Irmandade Santa Casa de Misericordia de Porto Alegre
      • Presidente Prudente, 브라질, 19013-050
        • Hospital Regional do Cancer Hospital de Esperanca
      • Salvador, 브라질, 41253-190
        • IDOR - Regional Bahia
      • Santa Cruz do Sul, 브라질, 96835-090
        • Hospital Ana Nery Santa Cruz do Sul
      • Santo André, 브라질, 09060-870
        • CEPHO Centro de Estudos e Pesquisa de Hematologia e Oncologia
      • São Paulo, 브라질, 01509 900
        • Fundacao Antonio Prudente A C Camargo Cancer Center
      • São Paulo, 브라질, 01246 000
        • Fundacao Faculdade de Medicina - Instituto do Cancer do Estado de Sao Paulo
      • São Paulo, 브라질, 05652 900
        • Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein
      • São Paulo, 브라질, 1321 001
        • Real e Benemerita Associacao Portuguesa de Beneficencia
      • A Coruña, 스페인, 15006
        • Hosp Univ A Coruna
      • Algeciras, 스페인, 11207
        • Hosp. Punta de Europa
      • Barcelona, 스페인, 08025
        • Fund. Puigvert
      • Cadiz, 스페인, 11009
        • Hosp. Puerta Del Mar
      • Castellon, 스페인, 12004
        • Hosp. Gral. Univ. de Castellon
      • L'Hospitalet de Llobregat, 스페인, 08907
        • Hosp. Univ. de Bellvitge
      • Lugo, 스페인, 27003
        • Hosp. Univ. Lucus Augusti
      • Madrid, 스페인, 28041
        • Hosp. Univ. 12 de Octubre
      • Madrid, 스페인, 28046
        • Hosp. Univ. La Paz
      • Madrid, 스페인, 28027
        • Clinica Univ. de Navarra
      • Málaga, 스페인, 29010
        • Hosp Virgen de La Victoria
      • Santander, 스페인, 39008
        • Hosp. Univ. Marques de Valdecilla
      • Valencia, 스페인, 46010
        • Hosp. Clinico Univ. de Valencia
      • Buenos Aires, 아르헨티나, C1199
        • Hospital Italiano de Buenos Aires
      • Buenos Aires, 아르헨티나, C1417
        • Sociedade Beneficente de Senhoras Hospital Sirio Libanes
      • Córdoba, 아르헨티나, X5016KEH
        • Hospital Privado Centro Medico de Cordoba
      • Córdoba, 아르헨티나, 5000
        • Cemaic Centro Privado de Especialidades Medicas Ambulatorias e Investigacion Clinica
      • Córdoba, 아르헨티나, X5000KPH
        • Centro Urologico Profesor Bengio
      • Mar del Plata, 아르헨티나, B7602CBM
        • Hospital Privado de la Comunidad
      • Río Cuarto, 아르헨티나, 5800
        • Instituto Medico Rio Cuarto
      • Edinburgh, 영국, EH4 2XU
        • Western General Hospital
      • London, 영국, W6 8RF
        • Charing Cross Hospital
      • London, 영국, SW3 6JJ
        • The Royal Marsden NHS Trust
      • London, 영국, EC1A 7BE
        • St Bartholomews Hospital
      • Plymouth, 영국, PL6 8DH
        • Derriford Hospital
      • Scunthorpe, 영국, DN15 7BH
        • Scunthorpe General Hospital
      • Sheffield, 영국, S10 2JF
        • Sheffield Teaching Hospitals NHS Foundation Trust
      • Stevenage, 영국, SG1 4AB
        • Lister Hospital
      • Truro, 영국, TR1 3LJ
        • Royal Cornwall Hospitals NHS Trust - Royal Cornwall Hospital
      • Acquaviva delle Fonti, 이탈리아, 70021
        • Generale Regionale F. Miulli
      • Asti, 이탈리아, 14100
        • Ospedale Cardinal Massaia
      • Avellino, 이탈리아, 83100
        • Ospedale San Giuseppe Moscati di Avellino
      • Castelfranco Veneto, 이탈리아, 31033
        • Ospedale San Giacomo Apostolo, Guardia pediatrica territoriale
      • Milan, 이탈리아, 20141
        • Istituto Europeo di Oncologia
      • Milan, 이탈리아, 20132
        • Ospedale San Raffaele di Milano
      • Naples, 이탈리아, 80138
        • Fondazione G Pascale Istituto Nazionale Tumori IRCCS
      • Ravenna, 이탈리아, 48121
        • Ospedale S. Maria Delle Croci
      • Rome, 이탈리아, 00128
        • Istituto Nazionale Tumori Regina Elena
      • Bangalore, 인도, 560027
        • Health Care Global Enterprises pvt Ltd
      • Chandigarh, 인도, 160012
        • Post Graduate Institute of Medical Education And Research PGIMER
      • Gurugram, 인도, 122001
        • Artemis Hospital
      • Kolkata, 인도, 700094
        • Netaji Subhas chandra Bose Cancer Research Institute
      • Mumbai, 인도, 400012
        • Tata Memorial Hospital
      • Pune, 인도, 411040
        • CIMET s Inamdar Multispeciality Hospital
      • Fuji-shi, 일본, 417-8567
        • Fuji City General Hospital
      • Kanazawa, 일본, 920 8641
        • Kanazawa University Hospital
      • Kashihara-shi, 일본, 634-8522
        • Nara Medical University Hospital
      • Kisarazu-shi, 일본, 292-8535
        • Kimitsu Chuo Hospital
      • Kobe, 일본, 650 0047
        • Kobe City Medical Center General Hospital
      • Kumamoto, 일본, 860-0008
        • National Hospital Organization Kumamoto Medical Center
      • Nagano, 일본, 381-8551
        • Nagano Municipal Hospital
      • Nagasaki, 일본, 852-8501
        • Nagasaki University Hospital
      • Nagasaki, 일본, 852-8511
        • JRC Nagasaki Genbaku Hospital
      • Narashino-shi, 일본, 275-8580
        • Saiseikai Narashino Hospital
      • Toon-shi, 일본, 791-0295
        • Ehime University Hospital
      • Toyama, 일본, 930 0194
        • Toyama University Hospital
      • Ube, 일본, 755-8505
        • Yamaguchi University Hospital
      • Yokohama, 일본, 232 0024
        • Yokohama City University Medical Center
      • Beijing, 중국, 100730
        • Beijing Hospital
      • Beijing, 중국, 100034
        • Peking University First Hospital
      • Beijing, 중국, 101100
        • Beijing Luhe Hospital, Capital Medical University
      • Changchun, 중국, 130499
        • The First Bethune Hospital of Jilin University
      • Changsha, 중국, 410013
        • Hunan Province Cancer Hospital
      • Chengdu, 중국, 610044
        • West China Hospital Sichuan University
      • Chongqing, 중국, 400000
        • Chongqing University Cancer Hospital
      • Deyang, 중국, 618000
        • People's Hospital of Deyang City
      • Guangzhou, 중국, 430030
        • Sun Yat Sen University Cancer Center
      • Hangzhou, 중국, 310000
        • Zhejiang Provincial People's Hospital
      • Hangzhou, 중국, 310016
        • Sir Run Run Shaw Hospital Zhejiang University School of Medicine
      • Nanjing, 중국, 210008
        • Nanjing Drum Tower Hospital
      • Ningbo, 중국, 315010
        • The First Affiliated Hospital of Ningbo University
      • Shanghai, 중국, 200025
        • Ruijing Hospital Affiliated To Shanghai Jiaotong University School Of Medicine
      • Shanghai, 중국, 200400
        • Huadong Hospital Affiliated to Fudan University
      • Shenyang, 중국, 110004
        • Shengjing Hospital Of China Medical University
      • Tianjin, 중국, 300211
        • The Second Hospital Of Tianjin Medical University
      • Wenzhou, 중국, 325000
        • The First Affiliated Hospital of Wenzhou Medical University
      • Wuhan, 중국, 430030
        • TongJi Hospital of TongJi Medical College of Huazhong University of Science & Technology
      • Xi'an, 중국, 710061
        • First Affiliated Hospital of Medical College of Xi'an Jiaotong University
      • Yantai, 중국, 264000
        • Yantai Yuhuangding Hospital
      • Zhengzhou, 중국, 450008
        • Henan Cancer Hospital
      • Brno, 체코, 65691
        • Fakultni nemocnice u sv. Anny v Brne
      • Hradec Králové, 체코, 500 05
        • Fakultni nemocnice Hradec Kralove
      • Liberec, 체코, 460 01
        • Krajská nemocnice Liberec a.s.
      • Olomouc, 체코, 779 00
        • Fakultni nemocnice Olomouc
      • Prague, 체코, 100 34
        • Fakultni nemocnice Kralovske Vinohrady
      • Prague, 체코, 15006
        • Fakultni nemocnice v Motole
      • Prague, 체코, 140 59
        • Thomayerova nemocnice, Onkologicka klinika
    • Nova Scotia
      • Halifax, Nova Scotia, 캐나다, B3H 2Y9
        • Nova Scotia Health Authority
    • Ontario
      • Hamilton, Ontario, 캐나다, L8N 4A6
        • St Josephs Healthcare Hamilton
      • Toronto, Ontario, 캐나다, M5G 1Z5
        • Princess Margaret Cancer Centre University Health Network
    • Quebec
      • Montreal, Quebec, 캐나다, H2X 3E4
        • CHUM - Centre hospitalier universitaire de Montreal
      • Québec, Quebec, 캐나다, G1J1Z4
        • CHU de Quebec Universite Laval Hopital de l Enfant Jesus
      • Saint Jerome Quebec, Quebec, 캐나다, J7Z 2V4
        • Unite de Recherche Clinique du CISSS des Laurentides
      • Coimbra, 포르투갈, 3000-075
        • Ipo Coimbra
      • Lisbon, 포르투갈, 1769 001
        • Uls Santa Maria - Hosp. Santa Maria
      • Vila Nova de Gaia, 포르투갈, 4434 502
        • Uls Gaia Espinho
      • Bialystok, 폴란드, 15 276
        • Uniwersytecki Szpital Kliniczny w Bialymstoku
      • Bydgoszcz, 폴란드, 85 048
        • IN VIVO Sp. z o.o
      • Lublin, 폴란드, 20 708
        • Wojewodzki Szpital Specjalistyczny im Stefana Kardynala Wyszynskiego SPZOZ
      • Piotrkow Trybunalski, 폴란드, 97 300
        • Centrum Medyczne
      • Poznan, 폴란드, 61 731
        • Clinical Research Center sp z o o MEDIC R s k
      • Słupsk, 폴란드, 76-200
        • Wojewodzki Szpital Specjalistyczny im Janusza Korczaka
      • Warsaw, 폴란드, 02-781
        • Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy
      • Warsaw, 폴란드, 02-647
        • Provita Poliklinika
      • Wroclaw, 폴란드, 50 556
        • Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu
      • Bordeaux, 프랑스, 33000
        • Polyclinique Bordeaux Nord Acquitaine
      • Clermont-Ferrand, 프랑스, 63003
        • CHU Gabriel-Montpied
      • Grenoble, 프랑스, 38043
        • CHU Grenoble
      • Limoges, 프랑스, 87000
        • Polyclinique de Limoges - Francois Chenieux
      • Lyon, 프랑스, 69437
        • Hôpital Edouard Herriot
      • Nantes, 프랑스, 44093
        • CHU de Nantes hotel Dieu
      • Nîmes, 프랑스, 30029
        • CHU Nimes
      • Orléans, 프랑스, 45067
        • Centre Hospitalier Regional d'Orleans (CHRO) - Hopital La Source
      • Paris, 프랑스, 75013
        • Hôpital Universitaire Pitié-Salpêtrière
      • Paris, 프랑스, 75018
        • APHP - Hopital Bichat - Claude Bernard
      • Paris, 프랑스, 75960
        • Groupe Hospitalier Diaconesses Croix Saint Simon
      • Paris, 프랑스, 75015
        • Hopital Europeen Georges-Pompidou
      • Quint-Fonsegrives, 프랑스, 31130
        • Clinical La Croix Du Sud - Ramsay Santé
      • Rennes, 프랑스, 35000
        • Chu Rennes Hopital Pontchaillou
      • Strasbourg, 프랑스, 67200
        • Institut de Cancerologie Strasbourg Europe ICANS
      • Toulouse, 프랑스, 31059
        • CHU Rangueil
      • Heidelberg, 호주, 3084
        • Austin Health
      • Macquarie University, 호주, 2109
        • Macquarie University Hospital
      • Nedlands, 호주, 6009
        • Hollywood Private Hospital
      • South Brisbane, 호주, 4101
        • Mater Hospital Brisbane

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Histologically confirmed initial diagnosis by local pathology (within 90 days of the most recent signed informed consent) of high grade non-muscle invasive bladder cancer (HR-NMIBC) (high-grade Ta, any T1 or carcinoma in-situ [CIS]), in participants who are Bacillus Calmette Guérin (BCG)-naïve
  • BCG-naïve (participants who have not received prior intravesical BCG or who previously received but stopped BCG more than 3 years before date of randomization are eligible)
  • All visible papillary disease must be fully resected (absent) prior to date of randomization and documented at baseline cystoscopy. Local urine cytology at screening must be negative or atypical (for high-grade urothelial carcinoma [HGUC]) for patients with papillary only disease (without CIS)
  • Eastern Cooperative Oncology Group (ECOG) performance status Grade 0, 1, or 2
  • All adverse events associated with any prior surgery and/or intravesical therapy must have resolved to common terminology criteria for adverse events (CTCAE) version 5.0 Grade less than (<) 2 prior to date of randomization
  • Participants must be willing to undergo all study procedures

Exclusion Criteria:

  • Presence or history of histologically confirmed, muscle invasive, locally advanced, nonresectable, or metastatic urothelial carcinoma (that is, greater than and equal to [>=] T2)
  • Must not have had urothelial carcinoma or histological variant at any site outside of the urinary bladder (that is, urethra, ureter, or renal pelvis). Ta/any T1/CIS of the upper urinary tract (including renal pelvis and ureter) is allowable if treated with complete nephroureterectomy more than 24 months prior to randomization
  • Presence of any bladder or urethral anatomic feature (example, urethral stricture) that, in the opinion of the investigator, may prevent the safe insertion, indwelling use, removal of TAR-200 or administration of intravesical BCG. Participants with tumors involving the prostatic urethra in men will be excluded
  • A history of clinically significant polyuria with recorded 24-hour urine volumes greater than 4000 milliliters (mL)
  • Indwelling catheters are not permitted; however, intermittent catheterization is acceptable

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Treatment Group A: TAR-200 + Cetrelimab

Participants will receive intravesical TAR-200 once every 3 weeks (Q3W) and cetrelimab.

Cetrelimab will be administered.

다른 이름들:
  • JNJ-63723283

TAR-200 will be administered intravesically.

다른 이름들:
  • JNJ-17000139
활성 비교기: Treatment Group B: Bacillus Calmette-Guerin (BCG) Vesiculture

Participants will receive intravesical BCG once every week for 6 weeks (induction) and then followed by once every week for 3 weeks starting at Weeks 12, 24, 48, 72, and 96 (maintenance).

BCG will be administered intravesically.

실험적: Treatment Group C: TAR-200 Alone

Participants will receive intravesical TAR-200 alone once Q3W.

TAR-200 will be administered intravesically.

다른 이름들:
  • JNJ-17000139

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Event-free Survival (EFS)
기간: Up to 5 years 2 months

EFS is defined as the time from randomization to either the time of the first recurrence of high-risk disease, progression, or death due to any cause, whichever occurs first. For participants with carcinoma In-situ (CIS), persistent disease at 6 months (Week 24) is also considered an EFS event. Progression is defined as: an increase of stage from Ta to T1 or from CIS to T1 or progression to muscle invasive bladder cancer (MIBC) (T greater than or equal to [>=] 2) or to lymph node (N+) or to distant disease (M+), whichever occurs first.

Up to 5 years 2 months

2차 결과 측정

결과 측정
측정값 설명
기간
Overall Complete Response (CR) Rate
기간: Up to 5 years 2 months

Overall CR will be measured by determining the percentage of participants with CIS who have no presence of high-risk disease at 6 months.

Up to 5 years 2 months
Duration of CR
기간: Up to 5 years 2 months

Duration of CR is defined from the time of first CR achieved to first evidence of recurrence, progression or death due to any cause (whichever occurs first) for participants who achieve a CR.

Up to 5 years 2 months
Recurrence-Free Survival (RFS)
기간: Up to 5 years 2 months

RFS is defined as the time from randomization to the time of the first recurrence of high-risk disease, or death due to any cause, whichever occurs first.

Up to 5 years 2 months
Time to Progression (TTP)
기간: Up to 5 years 2 months

TTP is defined as the time from randomization to the date of first documented evidence of disease progression or death due to disease progression, whichever occurs first.

Up to 5 years 2 months
Overall Survival (OS)
기간: Up to 5 years 2 months

OS is defined as the time from randomization to death, due to any cause.

Up to 5 years 2 months
Cancer Specific Survival (CSS)
기간: Up to 5 years 2 months

CSS is defined as the time from randomization to the date of death due to bladder cancer.

Up to 5 years 2 months
Number of Participants with Adverse Events (AEs) by Grades According to Common Terminology Criteria for Adverse Events (CTCAE)
기간: Up to 5 years 2 months

Number of participants with AEs by severity grade as assessed by CTCAE version 5 will be reported. Grade refers to the severity of AE as follows: Grade 1- Mild; Grade 2- Moderate; Grade 3- Severe; Grade 4- Life-threatening; Grade 5- Death related to adverse event.

Up to 5 years 2 months
Number of Participants with Adverse Events (AEs)
기간: Up to 5 years 2 months

Number of participants with AEs will be reported. An AE is any untoward medical occurrence in a clinical study participant administered a pharmaceutical (investigational or non-investigational) product. An AE does not necessarily have a causal relationship with the treatment. An AE can therefore be any unfavorable and unintended sign (including an abnormal finding), symptom, or disease temporally associated with the use of a medicinal (investigational or non-investigational) product, whether or not related to that medicinal (investigational or non-investigational) product.

Up to 5 years 2 months
Number of Participants with Change from Baseline in Laboratory Abnormalities
기간: Up to 5 years 2 months

Number of participants with change from baseline in laboratory abnormalities will be reported. Severity will be graded according to the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE) version 5.0. Severity scale ranges from Grade 1 (Mild) to Grade 5 (Death). Grade 1- Mild, Grade 2- Moderate, Grade 3- Severe, Grade 4- Life-threatening, and Grade 5- Death related to adverse event.

Up to 5 years 2 months
Number of Participants with Change from Baseline in Vital Signs Abnormalities
기간: Up to 5 years 2 months

Number of participants with change from baseline in vital signs (blood pressure [systolic and diastolic], heart rate, temperature, and weight) abnormalities will be reported.

Up to 5 years 2 months
Change from Baseline in European Organisation for Research and Treatment of Cancer Quality of life Questionnaire - Non-muscle Invasive Bladder Cancer EORTC QLQ- NMIBC 24
기간: Up to 5 years 2 months

EORTC QLQ-NMIBC 24 is a 24-item questionnaire for evaluating the Health-related quality of life (HRQoL) of participants with superficial (non-muscle-invasive) bladder cancer. The questionnaire is designed to supplement the quality of life questionnaire (QLQ-C30) and incorporates 6 multi-item scales and 5 single items. Ratings for each item range from 1 (not at all) to 4 (very much).

Up to 5 years 2 months
Time to Symptom Deterioration as Assessed by EORTC-QLQ-NMIBC 24 Scores
기간: Up to 5 years 2 months

EORTC QLQ-NMIBC 24 is a 24-item questionnaire for evaluating the HRQoL of participants with superficial (non-muscle-invasive) bladder cancer. The questionnaire is designed to supplement the QLQ-C30 and incorporates 6 multi-item scales and 5 single items. Ratings for each item range from 1 (not at all) to 4 (very much).

Up to 5 years 2 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 연구 책임자: Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2023년 3월 23일

기본 완료 (추정된)

2029년 9월 18일

연구 완료 (추정된)

2029년 9월 18일

연구 등록 날짜

최초 제출

2023년 1월 27일

QC 기준을 충족하는 최초 제출

2023년 1월 27일

처음 게시됨 (실제)

2023년 2월 6일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 25일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 24일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

기타 연구 ID 번호

  • CR109223
  • 2020-004506-64 (EudraCT 번호)
  • 17000139BLC3002 (기타 식별자: Janssen Research & Development, LLC)
  • 2023-507187-39-00 (레지스트리 식별자: EUCT number)
  • 2023 (미국 NIH 보조금/계약)

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

예

IPD 계획 설명

The data sharing policy of the Janssen Pharmaceutical Companies of Johnson & Johnson is available at www.janssen.com/clinical-trials/transparency. As noted on this site, requests for access to the study data can be submitted through Yale Open Data Access (YODA) Project site at yoda.yale.edu

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

예

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다